Показано 0 из 0
Дата |
---|
11:08 |
09.05.2024 |
08.05.2024 |
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
6.59
|
6.60
|
7.42
|
6.50
|
7.90
|
6.59
|
|
|
85 060 000.00
|
|
6.46
|
6.48
|
5.98
|
5.98
|
6.81
|
6.46
|
|
|
59 690 000.00
|
|
5.95
|
5.97
|
6.10
|
5.84
|
6.19
|
5.95
|
|
|
11 160 000.00
|
|
6.06
|
6.09
|
6.30
|
6.03
|
6.37
|
6.06
|
|
|
10 900 000.00
|
|
6.32
|
6.33
|
6.37
|
6.30
|
6.53
|
6.32
|
|
|
14 090 000.00
|
|
6.18
|
6.25
|
6.36
|
6.13
|
6.43
|
6.25
|
|
|
1 620 000.00
|
|
6.37
|
6.38
|
6.23
|
6.10
|
6.49
|
6.38
|
|
|
2 860 000.00
|
|
6.16
|
6.18
|
6.25
|
6.14
|
6.66
|
6.18
|
|
|
24 730 000.00
|
|
6.16
|
6.21
|
6.15
|
6.08
|
6.79
|
6.16
|
|
|
27 500 000.00
|
|
6.18
|
6.19
|
5.96
|
5.76
|
6.32
|
6.18
|
|
|
31 700 000.00
|
|
Laekna Inc is an investment holding company mainly engaged in the discovery, development and commercialization of innovative therapies for cancer and liver disease. The Company is mainly engaged in the research and development of drug candidates for monotherapy and combination therapy, focusing on the treatment of various cancers and liver fibrosis diseases.